ClinicalTrials.Veeva

Menu

Subconjunctival Injection of Allogeneic Mesenchymal Stem Cells in Severe Ocular Chemical Burn (SYMBOLpreclini)

F

Fondation Ophtalmologique Adolphe de Rothschild

Status

Completed

Conditions

Bone Marrow Donor

Treatments

Other: bone marrow harvest

Study type

Observational

Funder types

NETWORK

Identifiers

NCT03967275
EGN_2018_11

Details and patient eligibility

About

The objective of this pre-clinical study is to demonstrate the robustness of Bone Marrow derived Mesenchymal Stem Cells (BM-MSC) production, to treat patients with severe eye burns.

For bone marrow donors who agree to participate, a 10 ml BM sample will be collected apart the 1 liter BM dedicated to transplantation.

A maximum of three donors of allogeneic BM-MSCs will be included. A ready-to-use BM-MSC suspension will be produced and stored for 10 years to accumulate data about stability of cryopreserved cells.

Enrollment

7 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patient with a bone marrow donation planned

Exclusion criteria

  • The donor is finally not eligible
  • The harvest cannot be performed
  • The sample cannot be obtained during the BM harvest procedure

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems